This page contains exclusive content for the member of the following sections: TTS, ITA. Log in to view.
Presenter: Cristina, Dopazo, BARCELONA, Spain
Authors: Cristina Dopazo1, Girish Gupte2, Ahmed Taha2, Paolo Muiesan2, Jane Hartley2, Peter Bromley3, James Bennett3, Susan V. Beath2, Deirdre A. Kelly2, Khalid Sharif2, Darius F. Mirza2
Cristina Dopazo1, Girish Gupte2, Ahmed Taha2, Paolo Muiesan2, Jane Hartley2, Peter Bromley3, James Bennett3, Susan V. Beath2, Deirdre A. Kelly2, Khalid Sharif2, Darius F. Mirza2
1Department of HPB Surgery and Transplants, Hospital Vall d´Hebron, Barcelona, Spain; 2Liver Unit (including small bowel transplantation), Children´s Hospital, Birmingham, United Kingdom; 3Anaesthetic Department, Children´s Hospital, Birmingham, United Kingdom
Intestinal transplantation (with or without the liver) can have significant haemodynamic and metabolic demands on recipients.
Aim: To analyse the impact of pre-operative status and intra-operative metabolic events on outcome during the first six months post-intestinal transplantation.
Patients and Methods: 51 primary small bowel transplants (12- isolated intestinal transplant (IITx group) and 39- combined liver-intestinal transplant (CLITx group)) were included. Risk factors for early mortality analysed included recipient, donor, operative and post-operative variables.
Results:
|
IITX Median (range) |
CLITX Median (range) |
Age |
52 months (21-141) |
18 months (8-194) |
Cold ischemia time |
380 min (221-540) |
449min (265-740) |
Warm ischemia time |
29 min (21-45) |
40 min (29-66) |
BE 30min post-reperfusion |
-12.5 (-18.4 - -4) |
-6.8 (-22.6 - -5) |
Early complications (vascular complications, compartment syndrome, acute rejection) were higher in CLITx. Ten patients (19%, all in CLITx group) died in first six months.
In univariate and multivariate analyses, the factors showing independent predictive value for early mortality in CLITx group were:
Conclusion: CLITX patients with metabolic acidosis and persistently low platelet count (<50,000/dL) should be monitored closely in the first 6 months.
By viewing the material on this site you understand and accept that:
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada